Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer
Xifeng Wu and colleagues show that a common variant in the prostate stem cell antigen ( PSCA ) gene on 8q24 is associated with susceptibility to urinary bladder cancer. The risk allele truncates the amino terminus of the PSCA gene product and reduces PSCA promoter activity in bladder cancer cell lin...
Saved in:
Published in | Nature genetics Vol. 41; no. 9; pp. 991 - 995 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York
Nature Publishing Group US
01.09.2009
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Xifeng Wu and colleagues show that a common variant in the prostate stem cell antigen (
PSCA
) gene on 8q24 is associated with susceptibility to urinary bladder cancer. The risk allele truncates the amino terminus of the PSCA gene product and reduces
PSCA
promoter activity in bladder cancer cell lines.
We conducted a genome-wide association study on 969 bladder cancer cases and 957 controls from Texas. For fast-track validation, we evaluated 60 SNPs in three additional US populations and validated the top SNP in nine European populations. A missense variant (rs2294008) in the
PSCA
gene showed consistent association with bladder cancer in US and European populations. Combining all subjects (6,667 cases, 39,590 controls), the overall
P
-value was 2.14 × 10
−10
and the allelic odds ratio was 1.15 (95% confidence interval 1.10–1.20). rs2294008 alters the start codon and is predicted to cause truncation of nine amino acids from the N-terminal signal sequence of the primary
PSCA
translation product.
In vitro
reporter gene assay showed that the variant allele significantly reduced promoter activity. Resequencing of the
PSCA
genomic region showed that rs2294008 is the only common missense SNP in
PSCA
. Our data identify rs2294008 as a new bladder cancer susceptibility locus. |
---|---|
Bibliography: | SourceType-Scholarly Journals-1 ObjectType-Correspondence-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 These authors contributed equally to this work. |
ISSN: | 1061-4036 1546-1718 1546-1718 |
DOI: | 10.1038/ng.421 |